ZINC ACNE: |

Barrier Therapeutics to Participate in the 2006 RBC Capital Markets Healthcare Conference Market Wire via Yahoo! Finance
Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer, is scheduled to participate on the panel entitled "Skin Deep: The Future of Clinical Dermatology," being held at the 2006 RBC Capital Markets Healthcare Conference on Wednesday, December 13, 2006,
Dual-Acting Topical Gel May Stop Acne Breakouts Science Daily
University of Cincinnati (UC) dermatologists are testing a new topical gel designed to reduce abnormal clogging of the pores while simultaneously fighting off certain bacterial infections linked to severe acne development.
Beautiful skin, inside out New Straits Times
FOR most women, part of their morning and evening routines involve a skincare regimen of applying cleanser, toner and moisturiser. They do it to combat the signs of ageing and to maintain a youthful complexion.
Naturopathy: Food for better vision New Straits Times
I AM a 56-year-old pensioner with mild age-related macular degeneration (ARMD). I was told that there is no cure for ARMD but is there anything I can do to prevent it from developing into an advanced stage?
Warm milk and garlic? It might sound vile — but it'll beat the bugs Daily Mail
JANE CLARKE'Sbooks are read by millions and she acted as adviser to Jamie Oliver on his groundbreaking School Dinners TV programme. Here she answers your questions on strengthening your immune system
Barrier Therapeutics Announces Submission of Voluntary Dismissal of Securities Lawsuit Market Wire via Yahoo! Finance
Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that the putative securities class action lawsuit filed against the company, certain of its officers and certain of the underwriters for the company's 2004 initial public offering and 2005 secondary offering has been voluntarily dismissed, in its entirety and
zinc+acne: | | zinc+acne